Business
Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today
The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI software.
At the time of writing, the Resonance Health share price is up 38.7% to 21.5 cents. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.7% to 6,969 points.
What’s driving the Resonance Health share price?
The Resonance Health share price is surging today following the company’s positive FDA clearance announcement.
According to Resonance Health, the FDA has cleared the pathway for the company to begin commercialisation for its HepaFat-AI technology.
HepaFat-AI is a medical…
-
Noosa News15 hours agoChef Sophie Phipps prepares to open restaurant at 30-acre Alsahwa Estate
-
Noosa News13 hours agoMan charged over Brisbane bus driver attack; The latest on the crisis in the Middle East; AC/DC reveal Australian tour details
-
Business13 hours agoIs this the best ASX 200 share to buy for growth?
-
General22 hours agoThe Israel-Iran war: the moral failure of a policy of neutrality